Introduction. Cardiovascular diseases are the leading cause of death in the population, their diagnosis and prevention are of great importance nowadays. Ferrous metallurgy workers are exposed to occupational risk factors, which, together with a genetic predisposition, can induce and affect progression of diseases of the circulatory system. The Ala16Val (rs4880) polymorphism influences the functioning of the superoxide dismutase enzyme, which catalyzes the first step in the removal of reactive oxygen species, and can be therefore associated with cardiovascular diseases and comorbidities. Our objective was to study the relationship between SOD2 gene Ala16Val polymorphism and blood pressure, body mass index, and biochemical blood test parameters (total cholesterol and glucose levels) in iron and steel production employees. Materials and methods. The study cohort included ninety eight 24 to 66 years (mean: 48.8 ± 8.3 years) male patients working in the converter shop of a metallurgical plant. Genomic DNA was isolated using the LumiPure kit (Lumiprobe, Russia) in accordance with the manufacturer’s instructions for use. Genotyping was performed using a QuantStudioTM 3 real-time PCR system (ThermoFisher, USA) and a commercial SNP-Screen kit (Synthol, Russia). Results. The Val/Val genotype was associated with higher systolic and diastolic blood pressure, and total blood cholesterol. Limitations. The study limitations include the lack of comprehensive data on working conditions in the sanitary and hygienic characteristics presented. There is no control group in the study, which does not allow assessing the contribution of occupational risk factors to the development of cardiovascular diseases in carriers of the Val/Val genotype. However, our sample can be considered representative, which allows applying the findings to assessing health risks for the adult working-age population involved in ferrous metals production with account for regional features. Conclusion. We assume that the Val/Val genotype is associated with risk factors for cardiovascular disease in the metallurgists due to the reduced antioxidant potential.
Authors analyzed the relationship of the most studied polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, GSTP1) with the risk of developing diseases in the territory of the Russian Federation. The authors analyzed domestic articles on gene polymorphisms and their association with various conditions. A systematic review of scientific papers was carried out using the following electronic databases: Cyberleninka, Electronic Library and Google Scholar, which searched for glutathione transferase (GST) gene polymorphisms from 1900 to 2020. The following keywords were used for the search: “GST polymorphism”. The search for articles was carried out in English but took into account the results obtained only in the territory of the Russian Federation. The search for scientific publications was independently checked and compared to filter out duplicate articles. The sample size, the number of loci included in the analysis, and the analyzed population (ethnic group) are essential in studying the relationship between glutathione S-transferase gene polymorphisms and the development of diseases. In general, the analysis of the articles makes it possible to reveal the association between the polymorphisms of the glutathione-S-transferase genes and the high risk of developing oncological diseases, respiratory diseases and other pathologies. This article did not consider the relationship of polymorphisms with reproductive pathologies because this topic includes a large amount of work and requires separate consideration. The least studied issue is the relationship between polymorphisms of genes for biotransformation of xenobiotics and the development of occupational diseases.
Introduction. Workers of industrial enterprises and the population living nearby are at risk of lead poisoning. Lead exposure can lead to irreversible negative consequences for the body, including hepatic and renal dysfunction, hematopoietic damage, cognitive dysfunction, and impairment of the genetic apparatus of the human cell. In this regard, it is necessary to study characteristics of the toxic effect of lead oxide nanoparticles (PbO NPs) to determine their health effects and minimize related disorders and diseases. The purpose of the study was to determine the level of expression of the BAX, BCL-2, P53, GSTM1, GSTP1, and SOD2 genes in various organs of laboratory rats following the exposure to lead oxide nanoparticles. Materials and methods. Twenty mature female albino Wistar rats were used in a four month experiment with chronic inhalation exposure to PbO NPs, 10 animals per group (exposure and control). The mean concentration of PbO NPs in the inhaled air was 0.215 mg/m3. At the end of the exposure period, organ fragments from the decapitated animals were fixed in liquid nitrogen and subsequently stored in a freezer at –80 °C. Total RNA was isolated from tissues using the ExtractRNA reagent. The expression level was determined by quantitative reverse transcription real-time PCR. Results. The BAX expression in the liver of rats exposed to PbO NPs for 4 months was by 2.2 times higher than in the control group (p=0.009). We observed a trend towards an increase in the BAX/BCL-2 ratio in hepatocytes indicating apoptotic processes. The P53 expression level was by 1.4 times higher in the olfactory bulb of the exposed rats (p=0.025) when compared to the controls. No changes were found in the expression levels of antioxidant genes GSTM1, GSTP1, and SOD2. Limitations. The study was conducted using female Wistar rats with no potential sex differences taken into account. Conclusion. Chronic inhalation exposure to PbO NPs induces apoptosis in rat liver through the BAX/BCL-2 pathway and rat brain through the regulation of P53.
Introduction. Industrial pollution of the workplace air and the environment with lead oxide nanoparticles (PbO NPs) poses the risk of neurodegenerative diseases in workers of lead and copper smelters and the population living around these enterprises. Various studies showed the involvement of N-methyl-D-aspartate (NMDA) receptor expression in the mechanisms of lead toxicity. Materials and methods. During two months, outbred female rats were exposed to lead nanoparticles (PbO NPs) at a concentration of 0.2 mg/m3 in a “nose-only” inhalation exposure system. The behavioral responses of the rats were assessed using the open field and the elevated plus maze tests. Quantitative expression of the NMDA receptor genes (GRIN1, GRIN2A, GRIN2B) in the rat hippocampus was assessed using a real-time PCR. Statistical data analysis was carried out using the Mann-Whitney U test. Results. The neurotoxic effect of PbO NPs manifested itself in the suppression of GRIN2A gene expression in the hippocampus of experimental rats. The expression of the GRIN1 gene also showed a tendency to decrease in rats under effect of PbO NPs, while the expression of the GRIN2B gene did not change. The results of the open field test did not reveal any differences between the experimental and control groups of rats. The elevated plus maze test revealed a significant decrease in the number of entries into the open arms of the maze in rats from the experimental group. Limitations. This work was performed on female Wistar rats and does not take into account possible inter-gender differences. Conclusion. The results of the experiment demonstrated the neurotoxic effect of PbO NPs including the reduced expression level of the GRIN2A gene of the NMDA receptor and a decrease in the proportion of time spent in the open arms in the elevated plus maze test.